New technique might allow surgeons to identify edges of cancers
Ji et al/Science Translational Medicine
A tiny probe equipped with a laser might reveal what the human eye doesn’t always see: the difference between a tumor and healthy tissue. A new study suggests the device might provide brain surgeons with a roadmap as they go about the delicate business of removing tumors.
Surgeons try to excise as much of brain tumors as possible, but they risk harming the patient if they remove healthy tissue. “This problem,” says surgeon Daniel Orringer of the University of Michigan in Ann Arbor, “has vexed brain surgeons for as long as they have taken out tumors,” since the first half of the 20th century. “Basically, we do it by feel — the texture, color and vascularity of the tissues. Tumors tend to bleed a little more than normal brain.”
Although removing and testing tissue samples, or biopsies, can help to characterize the tissue at the tumor margins, it’s a cumbersome and time-consuming process. In the new study, Orringer and his colleagues instead exposed such borderline brain tissues to a weak laser. Then they used Raman spectroscopy, a technique that reveals vibrations of specific chemical bonds in tissues. The revved up form of Raman spectroscopy that the researchers used is sensitive enough to distinguish between proteins and lipids. Since tumors are higher in protein than healthy brain tissue, the authors designed the technique to present protein signatures as blue images on a screen, and lipids as green.
Using the device as a probe, the researchers examined human brain tumor cells that had been implanted in live mice. The device could distinguish where the new tumor ended and healthy tissue began. A separate analysis of tissue that had recently been removed from a human brain cancer patient similarly revealed stark differences between the tumor and normal tissue. The findings appear in the Sept. 4 Science Translational Medicine.
The study offers “a very exciting advance,” says chemist Ji-Xin Cheng of Purdue University in West Lafayette, Ind.. The research establishes that visualization of the tumor margin using Raman spectroscopy is possible in a living animal, he says.
In patients, this could streamline surgery, says study coauthor Sunney Xie, a physical chemist at Harvard University whose team developed the new imaging technology. “We don’t need a biopsy,” he says. “You can do it in real time.”
Xie and Orringer estimate it could take five years or more of testing to get regulatory approval to use the technique with patients.
M. Ji et al. Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy. Science Translational Medicine. Volume 5, Sept. 4, 2013, p. 201ra119. Doi: 10.1126/scitranslmed.3005954. [Go to];
A. Yeager. Insightful Light. Vol.174, August 2, 2008. Available online: [Go to]
D. Orringer et al. Extent of resection in patients with glioblastoma: Limiting factors, perception of resectability, and effect on survival. Journal of Neurosurgery. Vol. 117, November 2012, p. 851. [Go to]
S.N. Kalkanis et al. The role of surgical resection in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline. Journal of Neuro-Oncology. Volume 96, January 2010, p. 33. [Go to]
C. Freudiger et al. Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy. Science. Volume 322, Dec. 19, 2008, p. 1857. doi: 10.1126/science.1165758. [Go to]
B. Saar et al. Video-rate molecular imaging in vivo with stimulated Raman scattering. Science. Volume 330, Dec. 3, 2010, p. 1368. doi: 10.1126/science.1197236. [Go to]